Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias
- PMID: 38447587
- PMCID: PMC11031244
- DOI: 10.1093/jamia/ocae032
Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias
Abstract
Background: Alzheimer's disease and related dementias (ADRD) affect over 55 million globally. Current clinical trials suffer from low recruitment rates, a challenge potentially addressable via natural language processing (NLP) technologies for researchers to effectively identify eligible clinical trial participants.
Objective: This study investigates the sociotechnical feasibility of NLP-driven tools for ADRD research prescreening and analyzes the tools' cognitive complexity's effect on usability to identify cognitive support strategies.
Methods: A randomized experiment was conducted with 60 clinical research staff using three prescreening tools (Criteria2Query, Informatics for Integrating Biology and the Bedside [i2b2], and Leaf). Cognitive task analysis was employed to analyze the usability of each tool using the Health Information Technology Usability Evaluation Scale. Data analysis involved calculating descriptive statistics, interrater agreement via intraclass correlation coefficient, cognitive complexity, and Generalized Estimating Equations models.
Results: Leaf scored highest for usability followed by Criteria2Query and i2b2. Cognitive complexity was found to be affected by age, computer literacy, and number of criteria, but was not significantly associated with usability.
Discussion: Adopting NLP for ADRD prescreening demands careful task delegation, comprehensive training, precise translation of eligibility criteria, and increased research accessibility. The study highlights the relevance of these factors in enhancing NLP-driven tools' usability and efficacy in clinical research prescreening.
Conclusion: User-modifiable NLP-driven prescreening tools were favorably received, with system type, evaluation sequence, and user's computer literacy influencing usability more than cognitive complexity. The study emphasizes NLP's potential in improving recruitment for clinical trials, endorsing a mixed-methods approach for future system evaluation and enhancements.
Keywords: clinical trial; informatics; research recruitment.
© The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
All authors have no competing interests to declare.
Similar articles
-
Clinical research staff perceptions on a natural language processing-driven tool for eligibility prescreening: An iterative usability assessment.Int J Med Inform. 2023 Mar;171:104985. doi: 10.1016/j.ijmedinf.2023.104985. Epub 2023 Jan 6. Int J Med Inform. 2023. PMID: 36638583 Free PMC article.
-
A systematic review on natural language processing systems for eligibility prescreening in clinical research.J Am Med Inform Assoc. 2021 Dec 28;29(1):197-206. doi: 10.1093/jamia/ocab228. J Am Med Inform Assoc. 2021. PMID: 34725689 Free PMC article.
-
Combining human and machine intelligence for clinical trial eligibility querying.J Am Med Inform Assoc. 2022 Jun 14;29(7):1161-1171. doi: 10.1093/jamia/ocac051. J Am Med Inform Assoc. 2022. PMID: 35426943 Free PMC article.
-
Considerate mHealth design for older adults with Alzheimer's disease and related dementias (ADRD): A scoping review on usability barriers and design suggestions.Int J Med Inform. 2021 Aug;152:104494. doi: 10.1016/j.ijmedinf.2021.104494. Epub 2021 May 12. Int J Med Inform. 2021. PMID: 34015657 Review.
-
Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways.Pharmgenomics Pers Med. 2024 Feb 13;17:65-76. doi: 10.2147/PGPM.S396971. eCollection 2024. Pharmgenomics Pers Med. 2024. PMID: 38370334 Free PMC article. Review.
References
-
- World Health Organization. Global Dementia Observatory (GDO). World Health Organization. Updated 2022. Accessed April 11, 2022. https://www.who.int/data/gho/data/themes/global-dementia-observatory-gdo
-
- Kramarow EA, Tejada-Vera B.. Dementia mortality in the United States, 2000-2017. Natl Vital Stat Rep. 2019;68(2):1-29. - PubMed
-
- Alzheimer’s Disease International. World Alzheimer Report 2019: Attitudes to Dementia. 2019. Accessed April 11, 2022. https://www.alz.co.uk/research/WorldAlzheimerReport2019.pdf
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
